Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2024

Open Access 23-03-2024 | Rhabdomyosarcoma | Case report

Primary alveolar rhabdomyosarcoma of the brain: a case report

Authors: Layal Al Mahmasani, Marwan Najjar, Roula Hourany, Abeer Tabbarah, Sara Sinno, Nathalie Chamseddine, Reine Abou Zeidane, Ghid Amhaz, Bassem Youssef, Hazem I. Assi

Published in: Journal of Medical Case Reports | Issue 1/2024

Login to get access

Abstract

Background

Primary brain rhabdomyosarcoma is a rare primary brain malignancy with few case reports. The vast majority of cases of primary brain rhabdomyosarcoma occur in pediatric patients, and immunohistochemistry can distinguish it from embryonal subtypes; however, few cases of primary brain rhabdomyosarcoma in adults have been reported in the literature.

Case presentation

We report the case of a 26-year-old White male patient who was found to have primary brain alveolar rhabdomyosarcoma after developing headaches for several months. A brain MRI revealed a mixed cystic and solid tumor along the vermis of the cerebellum. The patient underwent a gross total surgical resection, which confirmed the diagnosis of alveolar rhabdomyosarcoma. Further staging workup for another primary focus or disseminated disease yielded negative results, confirming the diagnosis of primary alveolar rhabdomyosarcoma of the brain.

Conclusion

The standard of care for managing this rare type of brain tumor involves surgery with adjuvant chemoradiotherapy. Further studies should be conducted for a better diagnostic and therapeutic understanding.
Literature
1.
go back to reference Morgenstern D, Rees H, Sebire N, Shipley J, Anderson J. Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature. Pathol Oncol Res. 2008;14:233–8.CrossRefPubMed Morgenstern D, Rees H, Sebire N, Shipley J, Anderson J. Rhabdomyosarcoma subtyping by immunohistochemical assessment of myogenin: tissue array study and review of the literature. Pathol Oncol Res. 2008;14:233–8.CrossRefPubMed
2.
go back to reference Dropcho EJ, Allen JC. Primary intracranial rhabdomyosarcoma: case report and review of the literature. J Neurooncol. 1987;5(2):139–50.CrossRefPubMed Dropcho EJ, Allen JC. Primary intracranial rhabdomyosarcoma: case report and review of the literature. J Neurooncol. 1987;5(2):139–50.CrossRefPubMed
3.
go back to reference Al-Gahtany M, Shroff M, Bouffet E, Dirks P, Drake J, Humphreys R, et al. Primary central nervous system sarcomas in children: clinical, radiological, and pathological features. Childs Nerv Syst. 2003;19(12):808–17.CrossRefPubMed Al-Gahtany M, Shroff M, Bouffet E, Dirks P, Drake J, Humphreys R, et al. Primary central nervous system sarcomas in children: clinical, radiological, and pathological features. Childs Nerv Syst. 2003;19(12):808–17.CrossRefPubMed
4.
go back to reference Xu F, De Las Casas LE, Dobbs LJ Jr. Primary meningeal rhabdomyosarcoma in a child with hypomelanosis of Ito. Arch Pathol Lab Med. 2000;124(5):762–5.CrossRefPubMed Xu F, De Las Casas LE, Dobbs LJ Jr. Primary meningeal rhabdomyosarcoma in a child with hypomelanosis of Ito. Arch Pathol Lab Med. 2000;124(5):762–5.CrossRefPubMed
5.
go back to reference Khalatbari MR, Hamidi M, Moharamzad Y. Primary alveolar rhabdomyosarcoma of the brain with long-term survival. J Neurooncol. 2013;115(1):131–3.CrossRefPubMed Khalatbari MR, Hamidi M, Moharamzad Y. Primary alveolar rhabdomyosarcoma of the brain with long-term survival. J Neurooncol. 2013;115(1):131–3.CrossRefPubMed
6.
go back to reference Kelly KM, Womer RB, Sorensen PH, Xiong QB, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol. 1997;15(5):1831–6.CrossRefPubMed Kelly KM, Womer RB, Sorensen PH, Xiong QB, Barr FG. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol. 1997;15(5):1831–6.CrossRefPubMed
Metadata
Title
Primary alveolar rhabdomyosarcoma of the brain: a case report
Authors
Layal Al Mahmasani
Marwan Najjar
Roula Hourany
Abeer Tabbarah
Sara Sinno
Nathalie Chamseddine
Reine Abou Zeidane
Ghid Amhaz
Bassem Youssef
Hazem I. Assi
Publication date
23-03-2024
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2024
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-024-04471-w

Other articles of this Issue 1/2024

Journal of Medical Case Reports 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine